Evidence map›Paper›PMID 31598176›Full record

ArticleBeilstein journal of organic chemistry2019

Isolation of fungi using the diffusion chamber device FIND technology.

Benjamin Libor, Henrik Harms, Stefan Kehraus, Ekaterina Egereva, Max Crüsemann, Gabriele M König

Open access · diamondAbstract read
In one paragraph

Article in Beilstein journal of organic chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Benjamin LiborInstitute for Pharmaceutical Biology, University of Bonn, Nussallee 6, 53115 Bonn, Germany.
Henrik HarmsInstitute for Pharmaceutical Biology, University of Bonn, Nussallee 6, 53115 Bonn, Germany.ORCID https://orcid.org/0000-0003-3888-0536
Stefan KehrausInstitute for Pharmaceutical Biology, University of Bonn, Nussallee 6, 53115 Bonn, Germany.
Ekaterina EgerevaInstitute for Pharmaceutical Biology, University of Bonn, Nussallee 6, 53115 Bonn, Germany.
Max CrüsemannInstitute for Pharmaceutical Biology, University of Bonn, Nussallee 6, 53115 Bonn, Germany.ORCID https://orcid.org/0000-0001-6660-2715
Gabriele M KönigInstitute for Pharmaceutical Biology, University of Bonn, Nussallee 6, 53115 Bonn, Germany.ORCID https://orcid.org/0000-0003-0003-4916
University of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungi are an important source of bioactive metabolites. The Fungal one-step IsolatioN Device (FIND) technology allows the isolation of rare fungi from terrestrial and marine samples. The FIND comprises a multi-chambered micro agar plate, where initially only one fungal part (e.g., hyphal cell, mycelial fragment or spore) is located in each chamber. After inoculation the device is placed back into the original natural environment of sample collection, to ensure favourable growth conditions. Experiments were carried out with terrestrial soil and marine sediment, as well as sea water samples to validate this method. This yielded axenic cultures of 12 different filamentous fungi, one of them being the marine-adapted fungal strain

Indexed as

FINDfungal one-step isolation deviceHeydenia cf. alpinanatural productsterpenes

Identifiers

PMID31598176
PMCPMC6774082
OpenAlexW2973565940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.